Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Dix, SP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 34 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Quilitz, RE; Arnold, AD; Briones, GR; Dix, SP; Ippoliti, C; Kennedy, LD; Lucich, JL; Mehta, J; Peters, BG; Tice, DS
      Practice guidelines for lipid-based amphotericin B in stem cell transplantrecipients

      ANNALS OF PHARMACOTHERAPY
    2. Dix, SP
      Onsite wastewater treatment: A technological and management revolution part 1

      WATER-ENGINEERING & MANAGEMENT
    3. Dix, SP
      Onsite wastewater treatment. A technological and management revolution: Part 2

      WATER-ENGINEERING & MANAGEMENT
    4. Dix, SP; Geller, RB
      High-dose chemotherapy with autologous stem cell rescue in the outpatient setting

      ONCOLOGY-NEW YORK
    5. Dix, SP; Andriole, VT
      Lipid formulations of amphotericin B

      CURRENT CLINICAL TOPICS IN INFECTIOUS DISEASES, VOL 20
    6. Bishop, MR; Tarantolo, SR; Geller, RB; Lynch, JC; Bierman, PJ; Pavletic, ZS; Vose, JM; Kruse, S; Dix, SP; Morris, ME; Armitage, JO; Kessinger, A
      A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation

      BLOOD
    7. Dix, SP; Cord, MK; Howard, SJ; Coon, JL; Belt, RJ; Geller, RB
      Safety and efficacy of a continuous infusion, patient controlled antiemetic pump to facilitate outpatient administration of high-dose chemotherapy

      BONE MARROW TRANSPLANTATION
    8. Geller, RB; Dix, SP
      Oral chemotherapy agents in the treatment of leukaemia

      DRUGS
    9. DIX SP
      PHARMACOLOGY OF LIPID FORMULATIONS OF AMPHOTERICIN-B

      Infectious diseases in clinical practice
    10. OSOWSKI CL; DIX SP; LYNN M; DAVIDSON T; COHEN L; MIYAHARA T; SEXAUER MC; JOYCE R; YEAGER A; WINGARD JR
      AN OPEN-LABEL DOSE COMPARISON STUDY OF ONDANSETRON FOR THE PREVENTIONOF EMESIS ASSOCIATED WITH CHEMOTHERAPY PRIOR TO BONE-MARROW TRANSPLANTATION

      Supportive care in cancer
    11. DIX SP; NELSON VI
      THE ONSITE REVOLUTION - NEW TECHNOLOGY, BETTER SOLUTIONS

      Water engineering & management
    12. Camp, MJ; Wingard, JR; Gilmore, CE; Lin, LS; Dix, SP; Davidson, TG; Geller, RB
      Efficacy of low-dose dopamine in preventing amphotericin B nephrotoxicity in bone marrow transplant patients and leukemia patients

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    13. GELLER RB; DEVINE SM; OTOOLE K; PERSONS L; KELLER J; MAUER D; HOLLAND HK; DIX SP; PIOTTI M; REDEI I; CONNAGHAN G; HEFFNER LT; HILLYER CD; WALLER EK; WINTON EF; WINGARD JR
      ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH MATCHED UNRELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES USING A PREPARATIVE REGIMENOF HIGH-DOSE CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION

      Bone marrow transplantation
    14. DIX SP; CORD MK; HOWARD SJ; COON JL; BELT RJ; GELLER RB
      COMPARISON OF THE EFFICACY AND ASSOCIATED RESOURCE UTILIZATION BETWEEN CYCLOPHOSPHAMIDE (CY) COMBINED WITH G-CSF OR GM-CSF FOR MOBILIZATIONOF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)

      Blood
    15. DIX SP; CORD MK; HOWARD SJ; COON JL; BELT RJ; GELLER RB
      SAFETY AND EFFICACY OF A CONTINUOUS-INFUSION, PATIENT-CONTROLLED ANTIEMETIC PUMP TO FACILITATE OUTPATIENT ADMINISTRATION OF HIGH-DOSE CHEMOTHERAPY (HDC)

      Blood
    16. GELLER RB; DIX SP; BELT RJ; CORD MK; HOWARD SJ; COON JL
      MINIMUM RESOURCE UTILIZATION FOR PATIENTS (PTS) WITH BREAST-CANCER, LYMPHOMA, OR MULTIPLE-MYELOMA (MM) UNDERGOING MOBILIZATION (MOB) AND HIGH-DOSE CHEMOTHERAPY (HDC) FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS (PBSCT) AS OUTPATIENTS

      Blood
    17. DIX SP; WINGARD JR
      MANAGEMENT OF VIRAL-INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS

      CLINICAL IMMUNOTHERAPEUTICS
    18. HOLLAND HK; DIX SP; GELLER RB; DEVINE SM; HEFFNER LT; CONNAGHAN DG; HILLYER CD; HUGHES LL; MILLER RL; MOORE MR; WINTON EF; WINGARD JR
      MINIMAL TOXICITY AND MORTALITY IN HIGH-RISK BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN PLUS AUTOLOGOUS MARROW STEM-CELL TRANSPLANTATION AND COMPREHENSIVE SUPPORTIVE CARE

      Journal of clinical oncology
    19. DIX SP; GILMORE CE
      CYTOKINE THERAPY AFTER BONE-MARROW TRANSPLANTATION

      Pharmacotherapy
    20. DIX SP; WINGARD JR; MULLINS RE; JERKUNICA I; DAVIDSON TG; GILMORE CE; YORK RC; LIN LS; DEVINE SM; GELLER RB; HEFFNER LT; HILLYER CD; HOLLAND HK; WINTON EF; SARAL R
      ASSOCIATION OF BUSULFAN AREA-UNDER-THE-CURVE WITH VENOOCCLUSIVE DISEASE FOLLOWING BMT

      Bone marrow transplantation
    21. OSOWSKI CL; DIX SP; LIN LS; MULLINS RE; GELLER RB; WINGARD JR
      EVALUATION OF THE DRUG-INTERACTION BETWEEN INTRAVENOUS HIGH-DOSE FLUCONAZOLE AND CYCLOSPORINE OR TACROLIMUS IN BONE-MARROW TRANSPLANT PATIENTS

      Transplantation
    22. DIX SP; WINGARD JR
      AMPHOTERICIN-B LIPID COMPLEX - REVIEW OF SAFETY, PHARMACOKINETICS ANDEFFICACY

      Medicamentos de actualidad
    23. DIX SP; WINGARD JR
      AMPHOTERICIN-B LIPID COMPLEX - REVIEW OF SAFETY, PHARMACOKINETICS ANDEFFICACY

      Medicamentos de actualidad
    24. GELLER RB; GILMORE CE; DIX SP; LIN LS; TOPPING DL; DAVIDSON TG; HOLLAND HK; WINGARD JR
      RANDOMIZED TRIAL OF LOPERAMIDE VERSUS DOSE-ESCALATION OF OCTREOTIDE ACETATE FOR CHEMOTHERAPY-INDUCED DIARRHEA IN BONE-MARROW TRANSPLANT ANDLEUKEMIA PATIENTS

      American journal of hematology
    25. DEVINE SM; DIX SP; GELLER RB; HOLLAND HK; COLBAUGH J; CONNAGHAN DG; FLEMING WH; HILLYER CD; MULLINS R; WALLER EK; WINTON EF; WINGARD JR
      PHASE-I TRIAL OF BUSULFAN (BU), CYCLOPHOSPHAMIDE (CY), AND DIAZIQUONE(AZQ) FOLLOWING AUTOLOGOUS (AU) OR ALLOGENEIC (AL) BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    26. MIYAHARA TT; DIX SP; DEVINE SM; HOLLAND HK; CONNAGHAN DG; FLEMING WH; GELLER RB; HEFFNER LT; HILLYER CD; WALLER EK; WINTON EF; WINGARD JR
      EVALUATION OF SUPPORTIVE CARE GUIDELINES FOR MONITORING BREAST-CANCERBONE-MARROW TRANSPLANT (BMT) PATIENTS IN THE OUTPATIENT SETTING

      Blood
    27. DIX SP; BUCUR SZ; MULLINS RE; MCCULLOCH W; THOMAS GR; HILLYER CD; MCCLURE HM; STROBERT EA; ORKIN JL; WINTON EF
      STUDIES OF THE PHARMACOKINETICS AND TOXICITY OF ONCE-DAILY BOLUS INTRAVENOUS BUSULFAN IN NONHUMAN-PRIMATES

      Blood
    28. DEVINE SM; GELLER RB; DIX SP; CONNAGHAN DG; FLEMING WH; HEFFNER LT; HILLYER CD; HOLLAND HK; WALLER EK; WINTON EF; WINGARD JR
      TACROLIMUS (FK506) COMBINED WITH METHOTREXATE (MTX) IS EFFECTIVE IN PREVENTING ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) FOLLOWING RELATED DONOR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    29. DIX SP; DEVINE SM; GELLER RB; WINGARD JR
      RE - SEVERE INTERACTION BETWEEN METHOTREXATE AND A MACROLIDE-LIKE ANTIBIOTIC

      Journal of the National Cancer Institute
    30. DEVINE SM; WINTON EF; HOLLAND HK; GELLER RB; HEFFNER LT; HILLYER CD; MORRIS LE; RODEY GE; BEVERIDGE R; LYNCH J; KLEIN L; DIX SP; WINGARD JR
      SIMULTANEOUS ADMINISTRATION OF INTERLEUKEN-6 (RHIL-6) AND NEUPOGEN(R)(RHG-CSF) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FORBREAST-CANCER (BCA)

      Blood
    31. DEVINE SM; GELLER RB; HOLLAND HK; MORRIS LE; WINTON EF; HEFFNER LT; HILLYER CD; RODEY GE; DIX SP; OTOOLE K; ROUTENBERG K; VOGLER WR; MAUER D; ARO R; FITZSIMMONS WE; WINGARD JR
      FK506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST-DISEASE (GVHD) AFTER MATCHED UNRELATED DONOR (MUD) MARROW TRANSPLANTATION

      Blood
    32. DIX SP; MULLINS RE; JERKUNICA I; DAVIDSON TG; GILMORE CE; YORK RC; LIN LS; DEVINE SM; GELLER RB; HEFFNER LT; HILLYER CD; HOLLAND HK; SEAY TE; VOGLER WR; WINTON EF; WINGARD JR; SARAL R
      ASSOCIATION OF BUSULFAN AREA-UNDER-THE-CURVE (AUC) WITH VENOOCCLUSIVEDISEASE (VOD) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    33. GELLER RB; TOPPING DL; GILMORE CE; DIX SP; DAVIDSON TG; LIN LS; HOLLAND HK; WINGARD JR; SARAL R
      A RANDOMIZED, DOSE-ESCALATION TRIAL OF OCTREOTIDE VERSUS LOPERAMIDE FOR CHEMOTHERAPY-INDUCED DIARRHEA IN BONE-MARROW TRANSPLANT AND LEUKEMIA PATIENTS

      Blood
    34. SEAY TE; DEVINE SM; GELLER RT; HEFFNER LT; HILLYER C; HOLLAND HK; RODEY GE; SARAL R; VOGLER WR; WINTON EF; DIX SP; PASCUZZI CC; YORK RC; WINGARD JR
      HIGH-DOSE BUSULFAN (BU), VP-16, CYTOXAN (CY) WITH MARROW RESCUE (BMT)FOR MULTIPLE-MYELOMA (MM)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 15:20:27